Omada Health, Inc. filed a Form S-1 registration statement for an initial public offering on 2025-05-09. It has amended it 1 time. It filed its final prospectus on 2025-06-09, at a public offering price of $19.00 per share. Each fact below is quoted from the filing named with it.
What the filings say
Listing
We have been approved to list our common stock on the Nasdaq Global Select Market under the trading symbol "OMDA." We are an "emerging growth company" as defined under the U.S. federal securities laws and, as such, have elected to comply with certain re duced public company reporting requirements in this prospectus and may elect to do so in future filings.From the 424B4 filed 2025-06-09
Offering price
The initial public offering price per share is $19.00.From the 424B4 filed 2025-06-09
Use of proceeds
We currently intend to use the net proceeds from this offering for general corporate purposes, including working capital, operating expenses, and capital expenditures.From the 424B4 filed 2025-06-09
Revenue
Revenue increased by 38% from $122.8 million to $169.8 million for the years ended December 31, 2023 and 2024, respectively, and by 57% from $35.1 million to $55.0 million for the three months ended March 31, 2024 and 2025, respectively.From the S-1/A filed 2025-05-29
Net loss or income
We incurred net losses of $67.5 million and $47.1 million for the years ended December 31, 2023 and 2024, respectively, and $19.0 million and $9.4 million for the three months ended March 31, 2024 and 2025, respectively.From the S-1/A filed 2025-05-29
Timeline
| Filed | What it is | Filing |
|---|---|---|
| 2025-05-09 | Registration statement filed | S-1 |
| 2025-05-29 | Registration statement amended | S-1/A |
| 2025-06-09 | Final prospectus filed: the offering is priced | 424B4 |
Tools for this story
Each opens in a new tab, filled in for Omada Health, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A company that wants to sell shares to the public in the United States files a registration statement with the SEC: Form S-1 for a US company, Form F-1 for a foreign one. It amends that statement as the figures and terms are filled in, usually adding the expected price range shortly before the offering. Once the offering is priced it files its final prospectus under Rule 424(b)(4). A company that decides not to go ahead can ask for the registration statement to be withdrawn on Form RW.
Every row on this page is one of those filings, linked to the filing itself. The facts are the company's own sentences, quoted from the filing named beside each one and never reworded; where no filing states a fact in a sentence that can be read exactly, this page leaves it out. A filing is the company's statement of its plans and its figures, not a verification of them, and nothing here is investment advice.